Charles Schwab Investment Management Inc Xeris Biopharma Holdings, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 423,775 shares of XERS stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
423,775
Previous 402,872
5.19%
Holding current value
$2.09 Million
Previous $1.37 Million
70.4%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding XERS
# of Institutions
204Shares Held
84.7MCall Options Held
132KPut Options Held
69.4K-
Black Rock Inc. New York, NY10.3MShares$51 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$40.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.29MShares$21.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$16.8 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$16.4 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $672M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...